| |
|
|
|
Xtalks, online
2023 -6-26
Tuberculosis (TB) continues to be a global health threat, particularly affecting vulnerable populations, including children. This webinar aims to explore critical aspects of TB vaccine development, encompassing sample collection, including the application of microsampling, the definition and prioritization of biomarkers, functional characterization through flow cytometry, data analysis pipelines and the integration of new and potential future technologies.
Sample Collection:
Proper sample collection is crucial for successful clinical trials. The featured speakers will discuss how sample type is determined by analyte stability, downstream analysis and participant volume restrictions. Microsampling techniques will be highlighted as an innovative approach to support clinical pediatric studies, which minimize sample volumes and invasiveness while maintaining the integrity of the collected samples. The speakers will share insights on how microsampling can facilitate pediatric studies, contributing to improved TB vaccine evaluation and monitoring.
Biomarkers:
Defining and prioritizing biomarkers for TB vaccination is essential for understanding immune responses and identifying correlates of protection. This webinar will delve into the current research landscape, discussing challenges and opportunities in identifying biomarkers that can guide the development and evaluation of effective TB vaccines, with particular consideration for the pediatric population.
NODATA
New and Potential Future Technologies:
The webinar will explore new and future technologies that have the potential to advance TB vaccine development. From novel vaccine platforms to innovative diagnostic tools, attendees will gain insights into emerging technologies that hold promise for the prevention, diagnosis and treatment of TB, with a specific focus on pediatric populations.
Register for this webinar on accelerating the progress in TB vaccine development with insights from microsampling, biomarkers and data analysis.
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Professor Thomas Scriba MSc (Stell), DPhil (Oxon), Deputy Director (Immunology), South African Tuberculosis Vaccine Initiative (SATVI) Nicholas Woudberg, PhD, Head of Scientific Strategies, Synexa Life Sciences
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2023 -6-26
|
|
|
|
|
|
|
|
Registration:
|
|
Free registration
|
|
|
E-mail:
|
|
ajuurinen@xtalks.com
|
|
|
|
|
|
|
|
|